Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BGLC NASDAQ:MGRX OTCMKTS:MITI OTCMKTS:RNVA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$2.14+1.4%$2.16$1.07▼$15.60$5.10M4.06275,424 shs155,696 shsMGRXMangoceuticals$0.36-3.6%$0.40$0.16▼$2.75$6.36M2.27420,476 shs211,279 shsMITIMitesco$0.08-9.1%$0.08$0.04▼$0.40$1.84M4.88101,615 shs52,830 shsRNVARennova Health$0.00$0.00▼$0.00$4.31M21.14521,883 shs43,750 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab+1.42%-2.73%+8.35%-7.12%-28.19%MGRXMangoceuticals-3.07%-0.08%+4.91%-7.13%-82.25%MITIMitesco-9.09%-2.44%+16.11%-30.43%-75.60%RNVARennova Health0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$2.14+1.4%$2.16$1.07▼$15.60$5.10M4.06275,424 shs155,696 shsMGRXMangoceuticals$0.36-3.6%$0.40$0.16▼$2.75$6.36M2.27420,476 shs211,279 shsMITIMitesco$0.08-9.1%$0.08$0.04▼$0.40$1.84M4.88101,615 shs52,830 shsRNVARennova Health$0.00$0.00▼$0.00$4.31M21.14521,883 shs43,750 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab+1.42%-2.73%+8.35%-7.12%-28.19%MGRXMangoceuticals-3.07%-0.08%+4.91%-7.13%-82.25%MITIMitesco-9.09%-2.44%+16.11%-30.43%-75.60%RNVARennova Health0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBGLCBioNexus Gene Lab 1.00SellN/AN/AMGRXMangoceuticals 1.00SellN/AN/AMITIMitesco 0.00N/AN/AN/ARNVARennova Health 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MITI, MGRX, BGLC, and RNVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/9/2026BGLCBioNexus Gene Lab Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026MGRXMangoceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 6/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBGLCBioNexus Gene Lab$7.43M0.70N/AN/A$3.56 per share0.60MGRXMangoceuticals$460K13.31N/AN/A$0.93 per share0.38MITIMitesco$40K41.88$0.03 per share2.83($1.36) per share-0.06RNVARennova Health$18.69M0.00N/AN/AN/ANaNCompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBGLCBioNexus Gene Lab-$2.98M-$1.48N/AN/AN/A-54.70%-37.43%-32.88%N/AMGRXMangoceuticals-$20.64M-$1.49N/AN/AN/A-4,639.13%-112.00%-104.96%N/AMITIMitesco$500K-$0.33N/AN/AN/A-7,638.20%-2.18%-2,982.65%N/ARNVARennova Health-$7.73MN/AN/AN/AN/AN/AN/AN/AN/ALatest MITI, MGRX, BGLC, and RNVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2026Q1 2026MITIMitescoN/A-$0.05N/A-$0.05N/AN/A5/19/2026Q1 2026MGRXMangoceuticalsN/A-$0.22N/A-$0.22N/A$0.07 million5/15/2026Q1 2026BGLCBioNexus Gene LabN/A-$0.23N/A-$0.2250N/A$0.02 million4/14/2026Q4 2025BGLCBioNexus Gene LabN/A-$0.52N/A-$0.5220N/A$0.48 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBGLCBioNexus Gene LabN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/AMITIMitescoN/AN/AN/AN/AN/ARNVARennova HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBGLCBioNexus Gene Lab0.016.535.69MGRXMangoceuticalsN/A0.290.29MITIMitescoN/AN/AN/ARNVARennova HealthN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBGLCBioNexus Gene Lab18.85%MGRXMangoceuticals56.72%MITIMitesco0.01%RNVARennova HealthN/AInsider OwnershipCompanyInsider OwnershipBGLCBioNexus Gene Lab0.05%MGRXMangoceuticals16.00%MITIMitesco4.90%RNVARennova Health20.21%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBGLCBioNexus Gene Lab302.42 million2.42 millionNot OptionableMGRXMangoceuticals317.17 million14.42 millionNot OptionableMITIMitesco3020.94 million19.92 millionNot OptionableRNVARennova Health6043.05 billion34.35 billionNot OptionableMITI, MGRX, BGLC, and RNVA HeadlinesRecent News About These CompaniesRennova Health Inc (RNVA)May 2, 2025 | nasdaq.comPURA - Momentum in Puration Inc Shares Continues on Expanded ModelAugust 15, 2024 | br.advfn.comRNVA Rennova Health, Inc.April 17, 2024 | seekingalpha.comRENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARESMarch 26, 2024 | finance.yahoo.comRENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARESMarch 26, 2024 | globenewswire.comRennova Health Inc RNVAFebruary 17, 2024 | morningstar.comMRENNOVA HEALTH, INC. CEO PROVIDES JANUARY 2024 MESSAGE TO SHAREHOLDERSJanuary 16, 2024 | finance.yahoo.comINNOVAQOR, INC. CEO PROVIDES YEAR END MESSAGE TO SHAREHOLDERSDecember 20, 2023 | finance.yahoo.comRENNOVA HEALTH, INC. ANNOUNCES SIGNIFICANT DEBT RESTRUCTURINGOctober 25, 2023 | finance.yahoo.comRENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2023 SECOND QUARTER FINANCIAL STATEMENTSAugust 21, 2023 | finance.yahoo.comRENNOVA HEALTH, INC. ANNOUNCES THE OPENING OF ITS FIRST ALCOHOL AND DRUG TREATMENT FACILITYAugust 14, 2023 | finance.yahoo.comRENNOVA HEALTH, INC. PROVIDES UPDATE ON 2022 FINANCIALS AND MYRTLE RECOVERY CENTERSFebruary 22, 2023 | finance.yahoo.comIs Rennova Health Inc (RNVA) Stock a Good Investment?December 29, 2022 | aaii.comADOJ seeking Rennova Health return pandemic relief fundsNovember 30, 2022 | complianceweek.comCRENNOVA HEALTH, INC. PROVIDES Q3 2022 PERFORMANCE UPDATEOctober 20, 2022 | finance.yahoo.comRENNOVA HEALTH, INC. PROVIDES BUSINESS UPDATESeptember 14, 2022 | finance.yahoo.comRENNOVA HEALTH, INC. DISCUSSES PROGRESS AND PLANS FOR MENTAL AND BEHAVIORAL HEALTH DIVISION ...June 16, 2022 | kentuckynewera.comKRENNOVA HEALTH, INC. DISCUSSES PROGRESS AND PLANS FOR MENTAL AND BEHAVIORAL HEALTH DIVISION WITH THE STOCK DAY PODCASTJune 16, 2022 | finance.yahoo.comRENNOVA HEALTH, INC. DISCUSSES 2021 FINANCIAL RESULTS AND COMPANY PROGRESS WITH THE STOCK DAY PODCASTApril 27, 2022 | finance.yahoo.comUS probing coronavirus aid paid to closed Rennova Health hospitalApril 18, 2022 | beckershospitalreview.comBMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 20263 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPOBy Ryan Hasson | May 20, 2026The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on ItBy Chris Markoch | June 7, 2026MITI, MGRX, BGLC, and RNVA Company DescriptionsBioNexus Gene Lab NASDAQ:BGLC$2.14 +0.03 (+1.42%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$2.00 -0.14 (-6.31%) As of 06/12/2026 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Mangoceuticals NASDAQ:MGRX$0.36 -0.01 (-3.65%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$0.37 +0.02 (+4.57%) As of 06/12/2026 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.Mitesco OTCMKTS:MITI$0.08 -0.01 (-9.09%) As of 06/12/2026 01:37 PM EasternMitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.Rennova Health OTCMKTS:RNVARennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
